Your browser is no longer supported. Please, upgrade your browser.
Settings
BLU [NASD]
BELLUS Health Inc.
Index- P/E- EPS (ttm)-0.53 Insider Own3.30% Shs Outstand65.52M Perf Week0.23%
Market Cap331.23M Forward P/E- EPS next Y-0.79 Insider Trans0.00% Shs Float61.15M Perf Month7.58%
Income-31.80M PEG- EPS next Q-0.14 Inst Own65.61% Short Float4.85% Perf Quarter11.96%
Sales0.01M P/S22082.13 EPS this Y1.90% Inst Trans-0.03% Short Ratio2.21 Perf Half Y83.33%
Book/sh2.25 P/B1.96 EPS next Y- ROA-23.80% Target Price- Perf Year-51.06%
Cash/sh1.30 P/C3.37 EPS next 5Y- ROE-24.90% 52W Range2.01 - 12.03 Perf YTD43.79%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-64.09% Beta0.27
Dividend %- Quick Ratio18.10 Sales past 5Y- Gross Margin- 52W Low114.93% ATR0.28
Employees32 Current Ratio18.10 Sales Q/Q-42.90% Oper. Margin- RSI (14)52.35 Volatility7.00% 6.68%
OptionableYes Debt/Eq0.00 EPS Q/Q78.00% Profit Margin- Rel Volume0.20 Prev Close4.40
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume1.34M Price4.32
Recom- SMA203.04% SMA505.57% SMA20039.19% Volume77,952 Change-1.82%
Jan-29-21Initiated RBC Capital Mkts Outperform $8
Nov-18-20Initiated Evercore ISI Outperform $12
Jul-07-20Downgrade Guggenheim Buy → Neutral
Jun-26-20Initiated H.C. Wainwright Buy $28
Sep-30-19Initiated Jefferies Buy $20
Sep-30-19Initiated Guggenheim Buy $12
Sep-30-19Initiated Cowen Outperform
Apr-22-21 09:30AM  
09:07AM  
07:19AM  
06:30AM  
Apr-21-21 10:45PM  
05:30PM  
05:00PM  
03:45PM  
03:11PM  
02:00PM  
12:28PM  
11:00AM  
Apr-20-21 10:51AM  
Apr-19-21 08:48PM  
08:00PM  
01:22PM  
12:23PM  
11:40AM  
11:00AM  
06:30AM  
Apr-17-21 01:19PM  
Apr-16-21 11:05PM  
01:35PM  
01:00PM  
12:15PM  
11:45AM  
Apr-15-21 02:40PM  
02:19PM  
11:30AM  
11:00AM  
Apr-14-21 06:34PM  
06:00PM  
Apr-13-21 02:39PM  
01:02PM  
12:00PM  
11:35AM  
11:00AM  
11:00AM  
10:20AM  
09:19AM  
07:00AM  
Apr-12-21 09:30PM  
08:02PM  
01:25PM  
01:12PM  
01:00PM  
06:30AM  
Apr-10-21 05:45PM  
Apr-09-21 01:07PM  
11:40AM  
10:30AM  
09:00AM  
Apr-08-21 02:05PM  
01:30PM  
06:30AM  
12:30AM  
Apr-07-21 07:29PM  
07:00PM  
11:53AM  
11:50AM  
10:27AM  
10:15AM  
09:32AM  
Apr-06-21 07:15PM  
05:44PM  
01:00PM  
12:30PM  
11:45AM  
11:00AM  
06:30AM  
05:40AM  
Apr-04-21 10:55PM  
10:05PM  
Apr-02-21 01:17PM  
12:00PM  
12:00PM  
11:30AM  
11:00AM  
10:42AM  
10:15AM  
06:30AM  
Apr-01-21 09:13PM  
07:45PM  
12:50PM  
12:30PM  
Mar-31-21 07:45PM  
07:28PM  
07:00PM  
12:20PM  
11:53AM  
Mar-30-21 04:13PM  
02:45PM  
01:25PM  
12:10PM  
12:00PM  
11:00AM  
10:45AM  
10:05AM  
Mar-29-21 09:49PM  
11:00AM  
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of chronic cough and other hypersensitization disorders. Its lead drug candidate includes BLU-5937, an oral small molecule antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of chronic cough and chronic pruritus. The company was founded in 1993 and is headquartered in Laval, Canada.